Convalescent plasma for administration of passive antibodies against viral agents
Haematologica
.
2020 Dec 1;105(12):2710-2715.
doi: 10.3324/haematol.2020.267427.
Authors
Giovanni Di Minno
1
,
Pier Mannuccio Mannucci
2
,
James W Ironside
3
,
Carlo Federico Perno
4
,
Lutz Gürtler
5
,
Louis Aledort
6
Affiliations
1
Dipartimento di Medicina Clinica e Chirurgia, Centro Hub per le Emocoagulopatie, Napoli, Italy. diminno@unina.it.
2
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
3
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
4
Departmental Medicine Laboratory, ASST Niguarda Hospital, Milan, Italy.
5
Max von Pettenkofer Institute, Ludwig Maximilians University of Munich, Munich, Germany.
6
Mary Weinfeld Professor of Clinical Research in Hemophilia at the Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
PMID:
33256373
PMCID:
PMC7716269
DOI:
10.3324/haematol.2020.267427
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19 Serotherapy
COVID-19* / therapy
Coronavirus Infections*
Humans
Immunization, Passive
Plasma
SARS-CoV-2